Promega and Roche take up battle over PCR patents

Rex Dalton

Nature, 2000, vol. 404, issue 6773, 7-7

Abstract: SAN FRANCISCO The Swiss-based pharmaceutical company Hoffman-La Roche Inc. is facing a series of legal hearings over the validity of two key patents that it holds on the polymerase chain reaction (PCR) process.

Date: 2000
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/35003722 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:404:y:2000:i:6773:d:10.1038_35003722

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35003722

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().